×

Prevention of hyperinsulinemia in subjects undergoing growth hormone (GH) treatment

  • US 7,141,548 B2
  • Filed: 06/04/2004
  • Issued: 11/28/2006
  • Est. Priority Date: 04/09/2003
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for reducing the incidence of a statistically significant rise in plasma insulin levels in an animal or human subject undergoing treatment with growth hormone (GH), comprising providing the subject, during the growth hormone treatment period, with a restricted amount of a high-fat (HF) diet as the sole food source.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×